The world's largest food company is making a foray into the medical arena.
Nestle's purchasing the rights to a testing kit for infants with milk allergies.
Swiss Nestle are set to pay the current owners, France's DBV Technologies,
10 million euros up front, with a further 90 million dependent on successful development of the skin patch test.
As well as developing and marketing the experimental kit for cow's milk protein allergy.
ADVERTISEMENT
Nestle want to raise awareness of the condition.
In a bid to boost sales of products for babies with food intolerance.
And hopes it will eventually generate 10 billion dollars worth of business.
DVB's shares rose 5 percent on the news.